You are here

Anoro

AstraZeneca inhaler lags GSK drug in lung disease trial

AstraZeneca inhaler lags GSK drug in lung disease trial

Reuters

clinical trials

Bevespi Aerosphere

Flag link:

Are Glaxo's Successful New Drugs Enough to Drive Growth?

Are Glaxo's Successful New Drugs Enough to Drive Growth?

Yahoo/Zacks.com

Flag link:

GlaxoSmithKline's COPD drug Anoro receives European green light

GlaxoSmithKline's COPD drug Anoro receives European green light

Reuters

Flag link:

4 Biotech Stocks With Upcoming FDA Decision Dates

4 Biotech Stocks With Upcoming FDA Decision Dates

Seeking Alpha

Flag link:

Respiratory Drug Maker About to Take Off

Respiratory Drug Maker About to Take Off

Motley Fool

Flag link:

3 Potential Game Changers for COPD

3 Potential Game Changers for COPD

Motley Fool

Boehringer Ingelheim

Flag link:

Glaxo May Buy Theravance to Gain New Drugs, Piper Analysts Say

Glaxo May Buy Theravance to Gain New Drugs, Piper Analysts Say

Bloomberg

Flag link: